Radiation Oncologist and Co-Director of the Genitourinary Program, Shalini Moningi, MD, joins the Cancer Advances podcast to discuss the latest advances in radiation therapy for prostate cancer. Listen as Dr. Moningi talks about SBRT, adaptive radiation, emerging biomarker data, and how these innovations are reshaping treatment selection, toxicity profiles, and patient's quality of life.

Breast density affects 50% of women and can significantly impact both cancer risk and early detection. Breast Radiologist, Paulette Turk, MD, and Medical Breast Program Director, Lakshmi Khatri, MD, join the Cancer Advances Podcast to discuss breast density, its risk implications and the role of supplemental screening. Listen as they explain how Cleveland Clinic is defining practical screening pathways in an area where national guidelines continue to evolve.

Shahzad Raza, MD, Hematologist at Cleveland Clinic, joins the Cancer Advances podcast to share insights from the RedirecTT-1 study. This study, presented at the 2025 American Society of Hematology (ASH) Annual Meeting, explores combining two bispecific antibodies, talquetamab and teclistamab, for patients with relapsed/refractory multiple myeloma with extramedullary disease. Listen as Dr. Raza discusses disease biology, outcomes, safety considerations and why this approach could be a major step forward for high-risk myeloma care.